Your browser doesn't support javascript.
loading
SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants.
Jones, Meleri; Cunningham, Morven E; Wing, Peter; DeSilva, Sampath; Challa, Rupa; Sheri, Anjaneyulu; Padmanabhan, Seetharamaiyer; Iyer, Radhakrishnan P; Korba, Brent E; Afdhal, Nezam; Foster, Graham R.
Afiliación
  • Jones M; The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK.
  • Cunningham ME; The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK.
  • Wing P; The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK.
  • DeSilva S; The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK.
  • Challa R; Spring Bank Pharmaceuticals, Milford, Massachusetts.
  • Sheri A; Spring Bank Pharmaceuticals, Milford, Massachusetts.
  • Padmanabhan S; Spring Bank Pharmaceuticals, Milford, Massachusetts.
  • Iyer RP; Spring Bank Pharmaceuticals, Milford, Massachusetts.
  • Korba BE; Department of Microbiology & Immunology, Georgetown University Medical Centre, Washington, District of Columbia.
  • Afdhal N; Department of Microbiology & Immunology, Georgetown University Medical Centre, Washington, District of Columbia.
  • Foster GR; The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK.
J Med Virol ; 89(9): 1620-1628, 2017 09.
Article en En | MEDLINE | ID: mdl-28303593

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Hepacivirus / Factores Inmunológicos Límite: Humans Idioma: En Revista: J Med Virol Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Hepacivirus / Factores Inmunológicos Límite: Humans Idioma: En Revista: J Med Virol Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido